Neural response to evaluating depression predicts perceivers’ mental health treatment recommendations

Neural response to evaluating depression predicts perceivers’ mental health treatment... Nonstigmatized perceivers’ initial evaluations of stigmatized individuals have profound consequences for the well-being of those stigmatized individuals. However, the mechanism by which this occurs remains underexplored. Specifically, what beliefs about the stigmatized condition (stigma-related beliefs) shape how nonstigmatized perceivers evaluate and behave toward stigmatized individuals? We examined these questions with respect to depression-related stigmatization because depression is highly stigmatized and nondepressed individuals’ behavior (e.g., willingness to recommend treatment) directly relates to removing stigma and increasing well-being. In Study 1, we identified common stigma-related beliefs associated with depression (e.g., not a serious illness, controllable, threatening), and found that only perceptions that depression is a serious condition predicted nondepressed perceivers’ willingness to recommend mental health treatment. Moreover, perceivers’ beliefs that depression is a distressing condition mediated the relationship between perceived seriousness and treatment recommendations (Study 1). In Study 2, we used fMRI to disentangle the potential processes connecting distress to nondepressed perceivers’ self-reported treatment intentions. Heightened activity in the dorsomedial prefrontal cortex (dmPFC)—a region widely implicated in evaluating others—and the ventrolateral prefrontal cortex (vlPFC)—a region widely implicated in regulating negative emotions—emerged when nondepressed perceivers evaluated individuals who were ostensibly depressed. Beliefs that depression is a distressing condition mediated the relationship between dmPFC (but not vlPFC) activity and nondepressed individuals’ self-reported treatment recommendations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cognitive, Affective, & Behaviorial Neuroscience Springer Journals

Neural response to evaluating depression predicts perceivers’ mental health treatment recommendations

Loading next page...
 
/lp/springer_journal/neural-response-to-evaluating-depression-predicts-perceivers-mental-OxST0O84Dv
Publisher
Springer US
Copyright
Copyright © 2017 by Psychonomic Society, Inc.
Subject
Psychology; Cognitive Psychology; Neurosciences
ISSN
1530-7026
eISSN
1531-135X
D.O.I.
10.3758/s13415-017-0534-8
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial